Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 25, 2024
Hepatocellular
carcinoma
(HCC)
is
a
common
malignancy
worldwide,
and
its
development
closely
related
to
abnormalities
in
iron
metabolism.
This
study
aims
systematically
analyze
changes
metabolism
the
tumor
microenvironment
of
HCC
using
single-cell
sequencing
technology,
investigate
potential
mechanisms
by
which
regulation
affects
survival
liver
cancer
patients.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: April 12, 2024
Surgery,
chemotherapy,
and
endocrine
therapy
have
improved
the
overall
survival
postoperative
recurrence
rates
of
Luminal
A,
B,
HER2-positive
breast
cancers
but
treatment
modalities
for
triple-negative
cancer
(TNBC)
with
poor
prognosis
remain
limited.
The
effective
application
rapidly
developing
chimeric
antigen
receptor
(CAR)-T
cell
in
hematological
tumors
provides
new
ideas
cancer.
Choosing
suitable
specific
targets
is
crucial
applying
CAR-T
treatment.
In
this
paper,
we
summarize
therapy’s
potential
different
subtypes
based
on
existing
research
progress,
especially
TNBC.
CAR-based
immunotherapy
has
resulted
advancements
CAR-macrophages,
CAR-NK
cells,
CAR-mesenchymal
stem
cells
(MSCs)
may
be
more
safer
treating
solid
tumors,
such
as
However,
tumor
microenvironment
(TME)
side
effects
pose
challenges
to
immunotherapy.
cells-derived
exosomes
are
advantageous
therapy.
Exosomes
carrying
CAR
immense
value
provide
a
modality
good
effects.
review,
an
overview
development
discuss
progress
CAR-expressing
We
elaborate
TNBC
prospects
using
CAR-MSCs
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Feb. 11, 2025
Abstract
Chimeric
antigen
receptor
T
(CAR-T)
therapy
holds
promise
for
cancer
treatment
but
faces
challenges
with
using
fresh
patient
cells,
including
manufacturing
failures
and
logistical
hurdles.
Cryopreserved
peripheral
blood
mononuclear
cells
(PBMCs)
offer
a
potential
solution,
while
lentiviral
processes
have
been
reported
generating
CAR-T
from
these
few
studies
demonstrated
successful
PiggyBac
electroporation
methods.
Therefore,
the
objectives
of
our
study
were
twofold:
Firstly,
to
conduct
comparative
on
cryopreserved
PBMCs,
their
respective
preparations
CAR-T.
Secondly,
establish
preparation
process
PBMCs
through
optimization.
The
results
revealed
that
long-term
frozen
viability
in
relatively
stable
manner.
generated
exhibited
comparable
expansion
potential,
cell
phenotype,
differentiation
profiles,
exhaustion
markers,
cytotoxicity
against
human
ovarian
line
(SKOV-3)
those
derived
PBMCs.
Moreover,
optimization,
we
further
enhanced
proliferation
toxicity
This
approach
has
revolutionize
production
model
by
utilizing
healthy
donor
instead
cells.
shift
could
mitigate
issues
affecting
efficacy,
such
as
suboptimal
condition
following
illness
or
delays
preparation.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 11, 2025
Background
Ubiquitination,
a
critical
post-translational
modification,
plays
pivotal
role
in
regulating
protein
stability
and
activity,
influencing
various
aspects
of
cancer
development,
including
metabolic
reprogramming,
immune
evasion,
tumor
progression.
However,
the
specific
ubiquitination
hepatocellular
carcinoma
(HCC),
particularly
relation
to
microenvironment
(TME),
remains
poorly
understood.
This
study
aims
systematically
explore
shaping
TME
HCC,
with
focus
on
its
impact
progression
modulation.
Methods
We
performed
bioinformatics
analysis
by
integrating
multiple
publicly
available
HCC
datasets
assess
status
across
cell
types
TME,
plasma
cells,
fibroblasts,
endothelial
epithelial-mesenchymal
transition
(EMT)
cells.
Ubiquitination
scores
were
calculated
categorize
these
types,
survival
data,
along
spatial
transcriptomics,
employed
evaluate
how
different
levels
influence
In
vitro
experiments,
such
as
transwell,
CCK8,
wound
healing
assays,
used
further
investigate
key
gene
UBE2C
phenotypes.
Results
Our
revealed
that
ubiquitination-related
genes
are
significantly
upregulated
tissues,
high
expression
correlating
poor
prognosis
patients.
Pathway
showed
enriched
processes
cycle
regulation,
DNA
repair,
p53
signaling.
These
pathways
contribute
promoting
proliferation,
facilitating
matrix
remodeling,
enhancing
angiogenesis.
Notably,
UBE2C,
enzyme,
appears
play
potentially
inhibiting
anti-tumor
responses
reducing
system’s
ability
recognize
eliminate
Furthermore,
experimental
data
confirmed
overexpression
promotes
invasion,
metastasis,
supporting
remodeling.
Conclusion
reveals
multifaceted
regulatory
roles
HCC.
not
only
supports
proliferation
anti-apoptotic
functions
within
cells
but
also
modulating
activity
stromal
Among
all
genes,
emerges
potential
prognostic
biomarker
therapeutic
target
offering
new
directions
for
precision
treatment
future.
Frontiers in Oncology,
Journal Year:
2025,
Volume and Issue:
14
Published: Jan. 21, 2025
Hepatocellular
carcinoma
(HCC)
is
one
of
the
most
common
lethal
cancers
worldwide.
Natural
killer
cells
(NK
cells)
play
a
key
role
in
liver
immunosurveillance,
but
tumor
microenvironment,
NK
are
readily
depleted,
as
evidenced
by
down-regulation
activating
receptors,
reduced
cytokine
secretion,
and
attenuated
killing
function.
The
up-regulation
inhibitory
such
PD-1,
TIM-3,
LAG-3,
further
exacerbates
depletion
cells.
Combined
blockade
strategies
targeting
these
immunosuppressive
mechanisms,
combination
PD-1
inhibitors
with
other
pathways
(eg.
TIM-3
LAG-3),
have
shown
potential
to
reverse
cell
exhaustion
preclinical
studies.
This
article
explores
promise
innovative
HCC
immunotherapy,
providing
new
therapeutic
directions
for
optimizing
function
improving
drug
sensitivity.
Molecular Immunology,
Journal Year:
2025,
Volume and Issue:
182, P. 54 - 61
Published: April 4, 2025
Natural
Killer
(NK)
cells
are
a
vital
element
of
the
innate
immune
system,
and
NK
cell-based
therapies
have
demonstrated
efficacy
against
various
malignancies.
However,
targeting
solid
tumors
has
been
challenging
due
to
low
infiltration
into
effective
evasion
strategies
employed
by
tumors.
Recent
studies
shown
that
cell
derived
nanovesicles
(NK-NV)
can
not
only
replicate
functions
but
also
offer
more
advantages
in
clinical
applications.
They
capable
transporting
cellular
components
such
as
proteins,
nucleic
acids,
lipids
across
distances,
thereby
facilitating
intercellular
communication
among
within
tumor
microenvironment
(TME).
With
progress
nanomedical
technology,
these
vesicles
be
engineered
carry
range
functional
elements
therapeutic
agents
enhance
their
antitumoral
capabilities.
In
this
review,
we
summarize
current
available
literature
on
NK-NVs,
discuss
potential
biological
role
non-coding
RNAs
(ncRNAs),
explore
application
treatment
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Oct. 28, 2024
Current
research
is
focused
on
utilizing
EVs
as
a
biopsy
tool
to
improve
the
diagnostic
accuracy
of
HCC,
reduce
surgical
risk,
and
explore
their
potential
in
modulating
drug
resistance
advancing
immunotherapeutic
strategies.
Extracellular
vesicles
(EVs)
have
been
increasingly
recognized
important
non-invasive
biomarkers
hepatocellular
carcinoma
(HCC)
due
presence
variety
biomolecules
within
them,
such
proteins
RNAs,
etc.
play
key
role
early
detection,
diagnosis,
treatment,
prognostic
monitoring
HCC.
These
influence
development
HCC
therapeutic
response
ways,
including
influencing
tumor
microenvironment,
resistance,
participating
immune
regulatory
mechanisms.
In
addition,
specific
molecules
miRNAs
are
regarded
markers
for
treatment
recurrence
which
certain
space
prospects.
this
paper,
we
summarize
aspects
markers,
also
discuss
questions
that
may
be
faced
markers.